Designing and exploring active N '-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients (2015)
- Authors:
- USP affiliated authors: ZINGALES, BIANCA SILVANA - IQ ; SILVA, MARCELO NUNES - IQ ; TAVARES, LEOBERTO COSTA - FCF
- Unidades: IQ; FCF
- DOI: 10.1016/j.ejmech.2015.03.066
- Subjects: DOENÇA DE CHAGAS; TRYPANOSOMA CRUZI
- Language: Inglês
- Imprenta:
- Source:
- Título: European Journal of Medicinal Chemistry
- ISSN: 0223-5234
- Volume/Número/Paginação/Ano: v. 96, p. 330-339, 2015
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BERL, Fanny Palace et al. Designing and exploring active N '-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients. European Journal of Medicinal Chemistry, v. 96, p. 330-339, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2015.03.066. Acesso em: 26 jan. 2026. -
APA
Berl, F. P., Pasqualoto, K. F. M., Jorge, S. D., Zingales, B., Zorzi, R. R., Silva, M. N. da, et al. (2015). Designing and exploring active N '-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients. European Journal of Medicinal Chemistry, 96, 330-339. doi:10.1016/j.ejmech.2015.03.066 -
NLM
Berl FP, Pasqualoto KFM, Jorge SD, Zingales B, Zorzi RR, Silva MN da, Ferreira AK, Azevedo RA de, Teixeira SF, Tavares LC. Designing and exploring active N '-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients [Internet]. European Journal of Medicinal Chemistry. 2015 ; 96 330-339.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.ejmech.2015.03.066 -
Vancouver
Berl FP, Pasqualoto KFM, Jorge SD, Zingales B, Zorzi RR, Silva MN da, Ferreira AK, Azevedo RA de, Teixeira SF, Tavares LC. Designing and exploring active N '-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients [Internet]. European Journal of Medicinal Chemistry. 2015 ; 96 330-339.[citado 2026 jan. 26 ] Available from: https://doi.org/10.1016/j.ejmech.2015.03.066 - Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
- Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds
- 5-nitro-2-furfuriliden derivatives are active against Trypanosoma cruzi prevalent in human patients
- N'-[(5-nitrofuran-2-YL) methylene] substituted hydrazides as potentialanti-t. cruzi agents
- 5-Nitro-2-furfuriliden derivates as potent antileishmanial agents: in vitro evaluation and structure-activity relationship analyses
- Drug repurposing in chagas disease: chloroquine potentiates benznidazole activity against Trypanosoma cruzi In vitro and in vivo
- 24s alfa ribosomal rna as target for the detection of trypanosoma cruzi
- Polymorphism in a 24s alfa ribosomal rna region from strains of trypanosoma cruzi
- Ribossomal rna as a target for the detection of trypanosoma cruzi
- Potential use of 24s 'ALPHA' ribosomal rna as a target for the detection of trypanosoma cruzi
Informações sobre o DOI: 10.1016/j.ejmech.2015.03.066 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
